Table 1 Clinicopathologic features of NSCLC cases
From: Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC)
Characteristics | No. of patients (%) |
|---|---|
Gender | Â |
   Male | 66 (69) |
   Female | 30 (31) |
Age (mean years ± S.D.) | 58.9 ± 9.2 |
   ≤ 60 | 56 (58) |
   > 60 | 40 (42) |
Smoking history | Â |
   No | 30 (31) |
   Yes | 66 (69) |
Tumor size (mean cm ± S.D.) | 3.9 ± 1.7 |
   1-3 | 37 (38) |
   3-5 | 44 (46) |
   > 5 | 15 (16) |
Histologic type | Â |
   Adenocarcinoma (ADC) | 30 (31) |
   Squamous (SSC) | 66 (69) |
Histologic stage | Â |
   I | 54 (56) |
   II | 32 (34) |
   III | 10 (10) |
Lymph node metastasis | Â |
   No | 70 (73) |
   Yes | 26 (27) |
Pleural indentation | Â |
   No | 75 (78) |
   Yes | 21 (22) |
Invasion or Adhesion | Â |
   No | 65 (68) |
   Yes | 31 (32) |